Defence Therapeutics Stock Price on December 3, 2024

DTCFF Stock  USD 0.41  0.00  0.00%   
If you're considering investing in Defence OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Defence Therapeutics stands at 0.41, as last reported on the 11th of December 2024, with the highest price reaching 0.41 and the lowest price hitting 0.41 during the day. Defence Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0491, which denotes the company had a -0.0491% return per unit of risk over the last 3 months. Defence Therapeutics exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Defence Therapeutics' Standard Deviation of 3.22, variance of 10.39, and Mean Deviation of 1.04 to check the risk estimate we provide.
  
Defence OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0491

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsDTCFF

Estimated Market Risk

 3.3
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.16
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Defence Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Defence Therapeutics by adding Defence Therapeutics to a well-diversified portfolio.

Related Headline

Benitec Biopharma Headline on 3rd of December 2024

Filed transaction by Benitec Biopharma Ltd Director, 10 Percent Owner: . Grant, award or other acquisition pursuant to Rule 16b-3(d)

Defence Therapeutics Valuation on December 3, 2024

It is possible to determine the worth of Defence Therapeutics on a given historical date. On December 3, 2024 Defence was worth 0.41 at the beginning of the trading date compared to the closed value of 0.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Defence Therapeutics otc stock. Still, in general, we apply an absolute valuation method to find Defence Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Defence Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Defence Therapeutics' related companies.
 Open High Low Close Volume
  0.41    0.41    0.41    0.41    100.00  
12/03/2024
  0.41    0.41    0.41    0.41    1.00  
  0.41    0.41    0.41    0.41    1.00  
Backtest Defence Therapeutics  |  Defence Therapeutics History  |  Defence Therapeutics Valuation   PreviousNext  
Open Value
0.41
0.41
Closing Value
10.31
Upside

Defence Therapeutics Trading Date Momentum on December 3, 2024

On December 04 2024 Defence Therapeutics was traded for  0.41  at the closing time. The highest daily price throughout the period was 0.41  and the lowest price was  0.41 . There was no trading activity during the period 1.0. Lack of trading volume on 12/04/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% .

Defence Therapeutics Fundamentals Correlations and Trends

By evaluating Defence Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Defence Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Defence financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Defence Therapeutics OTC Stock history

Defence Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Defence is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Defence Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Defence Therapeutics stock prices may prove useful in developing a viable investing in Defence Therapeutics
Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biologicalbiosimilar therapeutic drugs for cancer and infectious diseases. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada. Defence Therapeutics is traded on OTC Exchange in the United States.

Defence Therapeutics OTC Stock Technical Analysis

Defence Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Defence Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Defence Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Defence Therapeutics Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Defence Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Defence Therapeutics December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Defence Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Defence Therapeutics shares will generate the highest return on investment. By undertsting and applying Defence Therapeutics otc stock market strength indicators, traders can identify Defence Therapeutics entry and exit signals to maximize returns

Defence Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Defence Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Defence OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Defence to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Defence OTC Stock analysis

When running Defence Therapeutics' price analysis, check to measure Defence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defence Therapeutics is operating at the current time. Most of Defence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Defence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defence Therapeutics' price. Additionally, you may evaluate how the addition of Defence Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stocks Directory
Find actively traded stocks across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges